We are a company dedicated to the social implementation of molecular simulation technologies developed in the Washizu Laboratory at the University of Hyogo. Our office is located on the University of Hyogo campus in Kobe’s Port Island, adjacent to the supercomputer Fugaku. We currently provide analysis and R&D support using large-scale molecular simulations, and we are also developing a molecular–fluid coupled simulator as well as mesoscale simulators for material surfaces based on particle methods.
One of the challenges of the early detection of dementia is the lack of a simple screening method to detect cognitive impairment. A simple non-invasive screening test, when established, will greatly motivate patients to receive the test and thus bring the full benefits of early diagnosis. Eye tracking-based cognitive assessment (ETCA) is a method with scientific and medical foundation that is accessible to everyone, enabling patients to make the best of early diagnosis. The assessment uses data obtained from biological movements, namely of the eyes, toward images or videos, such as the percentage of fixation duration on the correct images, percentage of successful gaze detection, and gaze plot statistics and graphs. This innovative method enables the non-invasive, simple, objective, and quantitative determination of cognitive functions. Users simply look at the monitor screen and follow the instruction displayed to obtain their cognitive assessment.
Manufacture and sale of photography and color measurement equipment related to color, images, and video; photography and color measurement services; inspection; research and development; education; consulting; and other related activities.
A startup engaged in the design, manufacturing, and sales of measurement devices using laser-plasma technology. It provides high-precision measurement and analysis solutions, enhancing efficiency and sophistication in research, development, and industrial applications.
AMI Inc. is a research and development–driven startup aiming to advance the development of AI-powered medical devices and the social implementation of telemedicine. Guided by our mission to "achieve a society where optimal medical care is accessible to everyone, everywhere, at any time," AMI is working toward the real-world deployment of the Super Stethoscope. The Super Stethoscope is a collective term encompassing hardware (Cardio-EGG), software (cloud-based diagnostic platform), technology (AI and Software as a Medical Device [SaMD]), and knowledge, among other components.
